Proposed mechanisms for the induction of insulin resistance by oxidative stress

Antioxidants and Redox Signaling

Volumn 7, Issue 11-12, 2005, Pages 1553-1567

  Bloch Damti, Asnat ^a   Bashan, Nava ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; FATTY ACID; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; GLYCOGEN; HYDROGEN PEROXIDE; I KAPPA B KINASE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; THIOCTIC ACID;

ANIMAL CELL; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVATION; FATTY ACID TRANSPORT; GENETIC TRANSCRIPTION; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; MICROSOME; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT; REVIEW;

ANIMALS; DIABETES MELLITUS; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HUMANS; INSULIN; INSULIN RESISTANCE; OXIDATIVE STRESS; PHOSPHOTRANSFERASES;

ANIMALIA;

EID: 28844461131     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2005.7.1553     Document Type: Review

References (165)

1. Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE, and White ME Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem 277: 1531-1537, 2002.
2. Alessi DR, Deak M, Casamayor A, Caudwell FB, Morrice N, Norman DG, Gaffney P, Reese CB, MacDougall CN, Harbison D, Ashworth A, and Bownes M. 3-Phos-phoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase. Curr Biol 7: 776-789, 1997.
3. Ammendola R, Mesuraca M, Russo T, and Cimino F. The DNA-binding efficiency of Sp1 is affected by redox changes. Eur J Biochem 225: 483-489, 1994.
4. Arnalich F, Hernanz A, Lopez-Maderuelp D, De la Fuente M, Arnalich FM, Andres-Mateos E, Fernandez-Capitan C, and Montiel C. Intracellular glutathione deficiency is associated with enhanced nuclear factor-kappaB activation in older non-insulin dependent diabetic patients. Free Radic Res 35: 873-884, 2001.
5. Bandyopadhyay G, Standaert ML, Galloway L, Moscat J, and Farese RV. Evidence for involvement of protein kinase C (PKC)-zeta and noninvolvement of diacylglycerol-sensitive PKCs in insulin-stimulated glucose transport in L6 myotubes. Endocrinology 138: 4721-4731, 1997.
6. Bast A and Haenen GR. Interplay between lipoic acid and glutathione in the protection against microsomal lipid peroxidation. Biochim Biophys Acta 963: 558-561, 1988.
7. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412, 1991.
8. Baynes JW and Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48: 1-9, 1999.
9. Bellomo G, Maggi E, Poli M, Agosta FG, Bollati P, and Finardi G. Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM. Diabetes 44: 60-66, 1995.
10. Bierhaus A, Chevion S, Chevion M, Hofmann M, Quehenberger P, Illmer T, Luther T, Berentshtein E, Tritschler H, Muller M, Wahl P, Ziegler R, and Nawroth PP. Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells. Diabetes 46: 1481-1490, 1997.
11. Bouzakri K, Roques M, Gual P, Espinosa S, Guebre-Egziabher F, Riou JP, Laville M, Le Marchand-Brustel Y, Tanti JF, and Vidal H. Reduced activation of phosphatidylinositol 3-kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes. Diabetes 52: 1319-1325, 2003.
12. Braiman L, Alt A, Kuroki T, Ohba M, Bak A, Tennenbaum T, and Sampson SR. Activation of protein kinase C zeta induces serine phosphorylation of VAMP2 in the GLUT4 compartment and increases glucose transport in skeletal muscle. Mol Cell Biol 21: 7852-7861, 2001.
13. Braiman L, Alt A, Kuroki T, Ohba M, Bak A, Tennenbaum T, and Sampson SR. Insulin induces specific interaction between insulin receptor and protein kinase C delta in primary cultured skeletal muscle. Mol Endocrinol 15: 565- 574, 2001.
14. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001.
15. Bucala R, Makita Z, Koschinsky T, Cerami A, and Vlassara H. Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci U S A 90: 6434-6438, 1993.
16. Caballero B. Vitamin E improves the action of insulin. Nutr Rev 51: 339-340, 1993.
17. Carlson CJ, Koterski S, Sciotti RJ, Poccard GB, and Rondinone CM. Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulation of GLUT4 expression. Diabetes 52: 634-641, 2003.
18. Carper DA, Sun JK, Iwata T, Zigler JS, Jr., Ibaraki N, Lin LR, and Reddy V Oxidative stress induces differential gene expression in a human lens epithelial cell line. Invest Ophthalmol Vis Sci 40: 400-406, 1999.
19. Chari SN, Nath N, and Rathi AB. Glutathione and its redox system in diabetic polymorphonuclear leukocytes. Am J Med Sci 287: 14-15, 1984.
20. Cheatham B, Vlahos CJ, Cheatham L, Wang L, Blenis J, and Kahn CR. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol 14: 4902-4911, 1994.
21. Chen Z, Hagler J, Palombella VJ, Melandri F, Scherer D, Ballard D, and Maniatis T. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev 9: 1586-1597, 1995.
22. Cinaz P, Hasanoglu A, Bideci A, and Biberoglu G. Plasma and erythrocyte vitamin E levels in children with insulin dependent diabetes mellitus. J Pediatr Endocrinol Metab 12: 93-196, 1999.
23. Clark SF, Molero JC, and James-DE. Release of insulin receptor substrate proteins from an intracellular complex coincides with the development of insulin resistance, J Biol Chem 275: 3819-3826, 2000,
24. Clerk A, Fuller SJ, Michael A, and Sugden PH. Stimulation of "stress-regulated" mitogen-activated protein kinases (stress-activated protein kinases/c-Jun N-terminal kinases and p38-mitogen-activated protein kinases) in perfused rat hearts by oxidative and other stresses. J Biol Chem 273: 7288-7234, 1998.
25. Cohen P, Alessi DR, and Cross DA. PDK1, one of the missing links in insulin signal transduction? FEBS Lett 410: 3-10, 1997.
26. Constantinescu A, Tritschler H, and Packer L. alpha-Lipoic acid protects against hemolysis of human erythrocytes induced by peroxyl radicals. Biochem Mol Biol Int 33: 669-679, 1994.
27. Costagliola C, Iuliano G, Menzione M, Nesti A, Simonelli F, and Rinaldi E. Systemic human diseases as oxidative risk factors in cataractogenesis. I. Diabetes. Ophthalmic Res 20: 308-316, 1988.
28. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, and Nicotera T. Oxidative damage to DNA in diabetes mellitus. Lancet 347: 444-445, 1996.
29. Davi G, Ciabattoni G, Consoli A, Mezzetti A, Falco A, Santarone S, Pennese E, Vitacolonna E, Bucciarelli T, Costantini F, Capani F, and Patrono C. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation 99: 224-229, 1999.
30. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, and Shulman GI. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103: 253-259, 1999.
31. Egawa K, Nakashima N, Sharma PM, Maegawa H, Nagai Y, Kashiwagi A, Kikkawa R, and Olefsky JM. Persistent activation of phosphatidylinositol 3-kinase causes insulin resistance due to accelerated insulin-induced insulin receptor substrate-1 degradation in 3T3-L1 adipocytes. Endocrinology 141: 1930-1935, 2000.
32. Egawa K, Maegawa H, Shimizu S, Morino K, Nishio Y, Bryer-Ash M, Cheung AT, Kolls JK, Kikkawa R, and Kashiwagi A. Protein-tyrosine phosphatase-1B negatively regulates insulin signaling in 16 myocytes and Fao hepatoma cells. J Biol Chem 276: 10207-10211, 2001.
33. Elbein SC. Perspective: the search for genes for type 2 diabetes in the post-genome era. Endocrinology 143: 2012-2018, 2002.
34. Eldar-Finkelman H and Krebs EG. Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action. Proc Nad Acad Sci U S A 94: 9660-9664, 1997.
35. Eriksson UJ and Borg LAH. Diabetes and embryonic malformations, Role of substrate-induced free-oxygen radical production for dysmorphogenesis in cultured rat embryos. Diabetes 42: 411-419, 1993.
36. Estrada DE, Ewart HS, Tsakiridis T, Volchuk A, Ramlal T, Tritschler H, and Klip A. Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid/thioctic acid: participation of elements of the insulin signaling pathway. Diabetes 45: 1798-1804, 1996.
37. Ford ES, Mokdad AH, Giles WH, and Brown DW. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 52: 2346-2352, 2003.
38. Frei B. Natural Antioxidants in Human Health and Disease. San Diego, CA: Academic Press, Inc., 1994.
39. Fryer LG, Hajduch E, Rencurel F, Salt IP, Hundal HS, Hardie DG, and Carling D. Activation of glucose transport by AMP-activated protein kinase via stimulation of nitric oxide synthase. Diabetes 49: 1978-1985, 2000.
40. Gallou G, Ruelland A, Legras B, Maugendre D, Allannic H, and Cloarec L. Plasma malondialdehyde in type 1 and type 2 diabetic patients. Clin Chim Acta 214: 227-234, 1993.
41. Gaster M, Staehr P, Beck-Nielsen H, Schroder HD, and Handberg A. GLUT4 is reduced in slow muscle fibers of type 2 diabetic patients: is insulin resistance in type 2 diabetes a slow, type 1 fiber disease? Diabetes 50: 1324-1329, 2001.
42. Giugliano D, Ceriello A, and Paolisso G. Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress? Metabolism 44: 363-368, 1995.
43. Giugliano D, Ceriello A, and Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 19: 257-267, 1996.
44. Gokkusu C, Palanduz S, Ademoglu E, and Tamer S. Oxidant and antioxidant systems in NIDDM patients: influence of vitamin E supplementation. Endocr Res 27: 377-386, 2001.
45. Goldstein BJ, Mahadev K, and Wu X. Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets. Diabetes 54: 311-321, 2005.
46. Gopaul NK, Anggard EE, Mallet AI, Betteridge DJ, Wolff SP, and Nourooz-Zadeh J. Plasma 8-epi-PGF2 alpha levels are elevated in individuals with noninsulin dependent diabetes mellitus. FEBS Lett 368: 225-229, 1995.
47. Greene EL, Nelson BA, Robinson KA, and Buse MG. alpha-Lipoic acid prevents the development of glucose-induced insulin resistance in 3T3-L1 adipocytes and accelerates the decline in immunoreactive insulin during cell incubation. Metabolism 50: 1063-1069, 2001.
48. Gual P, Gremeaux T, Gonzalez T, Le Marchand-Brustel Y, and Tanti JF. MAP kinases and mTOR mediate insulin-induced phosphorylation of insulin receptor substrate-1 on serine residues 307, 612 and 632. Diabetologia, 46: 1532-1542, 2003.
49. Gugliucci A, Menini T, and Stahl AJ. Susceptibility to copper-enhanced autoxidation of VLDL+LDL fractions from diabetic patients. Biochem Mol Biol Int 32: 139-147, 1994.
50. Guo D, Dunbar JD, Yang CH, Pfeffer LM, and Donner DB. Induction of Jak/STAT signaling by activation of the type 1 TNF receptor. J Immunol 160: 2742-2750, 1998.
51. Ha H and Lee H. Oxidative stress in diabetic nephropathy: basic and clinical information. Curr Diab Rep 1: 282-287, 2001.
52. Haber CA, Lam TK, Yu Z, Gupta N, Goh T, Bogdanovic E, Giacca A, and Fantus IG. N-Acetylcysteine (NAC) and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress. Am J Physiol Endocrinol Metab 285: E744-E753, 2003.
53. Haffner SM, Agil A, Mykkanen L, Stern MP, and Jialal I. Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM. Diabetes Care 18: 646-653, 1995.
54. Hagemann C and Blank JI. The ups and downs of MEK kinase interactions. Cell Signal 13: 863-875, 2001.
55. Halliwell B. Antioxidants: the basics-what they are and how to evaluate them. Adv Pharmacol 38: 3-20, 1997.
56. Halliwell B. Establishing the significance and optimal intake of dietary antioxidants: the biomarker concept. Nutr Rev 57: 104-113, 1999.
57. Han D, Handelman G, Marcocci L, Sen CK, Roy S, Kobuchi H, Tritschler HJ, Flohe L, and Packer L. Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization. Biofactors 6: 321-338, 1997.
58. Hansen PA, Gulve EA, Marshall BA, Gao J, Pessin JE, Holloszy JO, and Mueckler M. Skeletal muscle glucose transport and metabolism are enhanced in transgenic mice overexpressing the Glut4 glucose transporter. J Biol Chem 270: 1679-1684, 1995.
59. Harris ED. Regulation of antioxidant exzymes. FASEB J 6: 2674-2678, 1992.
60. Haruta T, Uno T, Kawahara J, Takano A, Egawa K, Sharma PM, Olefsky JM, and Kobayashi M. A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. Mol Endocrinol 14: 783-794, 2000.
61. Hayes GR and Lockwood DH. Role of insulin receptor phosphorylation in the insulinomimetic effects of hydrogen peroxide. Proc Natl Acad Sci U S A 84: 8115-8119, 1987.
62. Heller-Harrison RA, Morin M, Guilherme A, and Czech MP. Insulin-mediated targeting of phosphatidylinositol 3-kinase to GLUT4-containing vesicles. J Biol Chem 271: 10200-10204, 1996.
63. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, and Hotamisligil GS. A central role for INK in obesity and insulin resistance. Nature 420: 333-336, 2002.
64. Hofmann MA, Schiekofer S, Isermann B, Kanitz M, Henkels M, Joswig M, Treusch A, Morcos M, Weiss T, Borcea V, Abdel Khalek AK, Amiral J, Tritschler H, Ritz E, Wahl P, Ziegler R, Bierhaus A, and Nawroth PP. Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. Diabetologia 42: 222-232, 1999.
65. Itani SI, Ruderman NB, Schmieder F, and Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α. Diabetes 51: 2005-2011, 2002.
66. Jacob S, Henriksen EJ, Schiemann AL, Simon I, Clancy DE, Tritschler HJ, Jung WI, Augustin HJ, and Dietze GJ. Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid. Arzneimittelforschung 45: 872-874, 1995.
67. Jacob S, Streeper RS, Fogt DL, Hokama JY, Tritschler HJ, Dietze GJ, and Henriksen EJ. The antioxidant alpha-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle. Diabetes 45: 1024-1029, 1996.
68. Jacob S, Ruus P, Hermann R, Tritschler HJ, Maerker E, Renn W, Augustin HJ, Dietze GJ, and Rett K. Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. Free Radic Biol Med 27: 309-314, 1999.
69. Jain SK, McVie R, Duett J, and Herbst JJ. Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 38: 1539-1543, 1989.
70. Jiang G, Dallas-Yang Q, Liu F, Moller DE, and Zhang BB. Salicylic acid reverses phorbol 12-myristate-13-acetate (PMA)- and tumor necrosis factor alpha (TNFalpha)-induced insulin receptor substrate 1 (IRS1) serine 307 phosphorylation and insulin resistance in human embryonic kidney 293 (HEK293) cells. J Biol Chem 278: 180-186, 2003.
71. Jonas CR, Puckett AB, Jones DP, Griffith DP, Szeszycki EE, Bergman GF, Furr CE, Tyre C, Carlson JL, Galloway JR, Blumberg JB, and Ziegler TR. Plasma antioxidant status after high-dose chemotherapy: a randomized trial of parenteral nutrition in bone marrow transplantation patients. Am J Clin Nutr 12: 181-189, 2000.
72. Jordan ET, Hatfield PM, Hondred D, Talon M, Zeevaart JA, and Vierstra RD. Phytochrome A overexpression in transgenic tobacco. Correlation of dwarf phenotype with high concentrations of phytochrome in vascular tissue and attenuated gibberellin levels. Plant Physiol 107: 797-805, 1995.
73. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46: 3-19, 2003.
74. Kanety H, Feinstein R, Papa MZ, Hemi R, and Karasik A. Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J Biol Chem 270: 23780-23784, 1995.
75. Karpen CW, Cataland S, O'Dorisio TM, and Panganamala RV. Interrelation of platelet vitamin E and thromboxane synthesis in type 1 diabetes mellitus. Diabetes 33: 239-243, 1984.
76. Khamaisi M, Potashnik R, Tirosh A, Demshchak E, Rudich A, Tritschler H, Wessel K, and Bashan N. Lipoic acid reduces glycemia and increases muscle GLUT4 content in streptozotocin-diabetic rats. Metabolism 46: 763-768, 1997.
77. Klippel A, Kavanaugh WM, Pot D, and Williams LT. A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain. Mol Cell Biol 17: 338-344, 1997.
78. Konrad T, Vicini P, Kusterer K, Hoflich A, Assadkhani A, Bohles HJ, Sewell A, Tritschler HJ, Cobelli C, and Usadel KH. alpha-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes. Diabetes Care 22: 280-287, 1999.
79. Korpinen E, Groop PH, Akerblom HK, and Vaarala O. Immune response to glycated and oxidized LDL in IDDM patients with and without renal disease: Diabetes Care 20: 1168-1171, 1997.
80. Kozlovsky N, Rudich A, Potashnik R, and Bashan N. Reactive oxygen species activate glucose transport in L6 myotubes. Free Radic Biol Med 23: 859-869, 1997.
81. Kozlovsky N, Rudich A, Potashnik R, Ebina Y, Murakami T, and Bashan N. Transcriptional activation of the Glut1 gene in response to oxidative stress in L6 myotubes. J Biol Chem 272: 33367-33372, 1997.
82. Laaksonen DE, Atalay M, Niskanen L, Uusitupa M, Hanninen O, and Sen CK. Increased resting and exercise-induced oxidative stress in young IDDM men. Diabetes Care 19: 569-574, 1996.
83. Levy Y, Zaltsberg H, Ben-AmotzA, Kanter Y, and Aviram M. Dietary supplementation of a natural isomer mixture of beta-carotene inhibits oxidation of LDL derived from patients with diabetes mellitus. Am Nutr Metab 44: 54-60, 2000.
84. Liu YF, Paz K, Herschkovitz A, Alt A, Tennenbaum T, Sampson SR, Ohba M, Kuroki T, LeRoith D, and Zick Y. Insulin stimulates PKCzeta-mediated phosphorylation of insulin receptor substrate-1 (IRS-1). A self-attenuated mechanism to negatively regulate the function of IRS proteins. J Biol Chem 276: 14459-14465, 2001.
85. Maddux BA, See W, Lawrence JC Jr, Goldfine AL, Goldfine ID, and Evans JL. Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by mircomolar concentrations of alpha-lipoic acid. Diabetes 50: 404-410, 2001.
86. 2 and plays an integral role in insulin signal transduction. Mol Cell Biol 24: 1844-1854, 2004.
87. Mahadev K, Wu X, Zilbering A, Zhu L, Lawrence JT, and Goldstein BJ. Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes. J Biol Chem 276: 48662-48669, 2001.
88. Mahadev K, Zilbering A, Zhu L, and Goldstein BJ. Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade. J Biol Chem 276: 21938-21942, 2001.
89. Makimattila S, Liu ML, Vakkilainen J, Schlenzka A, Lahdenpera S, Syvanne M, Mantysaari M, Summanen P, Bergholm R, Taskinen MR, and Yki-Jarvinen H. Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care 22: 973-981, 1999.
90. Maxwell SR, Thomason H, Sandler D, Leguen C, Baxter MA, Thorpe GH, Jones AF, and Barnett AH. Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur J Clin Invest 27: 484-490, 1997.
91. McLellan AC, Thornalley PJ, Benn J, and Sonksen PH. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin Sci (Lond) 87: 21-29, 1994.
92. Muchova J, Liptakova A, Orszaghova Z, Garaiova I, Tison P, Carsky J, and Durackova Z. Antioxidant systems in polymorphonuclear leucocytes of type 2 diabetes mellitus. Diabet Med 16: 74-78, 1999.
93. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, and Brownlee M. Normalizing mitochondrial Superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790, 2000.
94. Nourooz-Zadeh J, Rahimi A, Tajaddini-Sarmadi J, Tritschler H, Rosen P, Halliwell B, and Betteridge DJ. Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia 40: 647-653, 1997.
95. Ogihara T, Asano T, Katagiri H, Sakoda H, Anai M, Shojima N, Ono H, Fujishiro M, Kushiyama A, Fukushima Y, Kikuchi M, Noguchi N, Aburatani H, Gotoh Y, Komuro I, and Fujita T. Oxidative stress induces insulin resistance by activating the nuclear factor-kappaB pathway and disrupting normal subcellular distribution of phosphatidylinositol 3-kinase. Diabetologia 47: 794-805, 2004.
96. Opara EC, Abdel-Rahman E, Soliman S. Kamel WA, Souka S, Lowe JE, and Abdel-Aleem S. Depletion of total antioxidant capacity in type 2 diabetes. Metabolism 48: 1414-1417, 1999.
97. Ou P, Tritschler HJ, and Wolff SP. Thioctic (lipoic) acid: a therapeutic metal-chelating antioxidant? Biochem Pharmacol 50: 123-126, 1995.
98. Ozes ON, Akca H, Mayo LD, Gustin JA, Maehama T, Dixon JE, and Donner DB. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc Natl Acad Sci U S A 98: 4640-4645, 2001.
99. Packer L, Witt EH, and Tritschler HJ. alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 19: 227-250, 1995.
100. Packer L, Tritschler HJ, and Wessel K. Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radic Biol Med 22: 359-378, 1997.
101. Packer L, Kraemer K, and Rimbach G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 17: 888-895, 2001.
102. Paolisso G, Di Maro G, Pizza G, D'Amore A, Sgambato S, Tesauro P, Varricchio M, and D'Onofrio K. Plasma GSH/GSSG affects glucose homeostasis in healthy subjects and non-insulin-dependent diabetics. Am J Physiol 263: E435-E440, 1992.
103. Paolisso G, D'Amore A, Di Maro G, Galzerano D, Tesauro P, Varricchio M, and D'Onofrio F. Evidence for a relationship between free radicals and insulin action in the elderly. Metabolism 42: 659-663, 1993.
104. Paolisso G, D'Amore A, Balbi V, Volpe.C, Galzerano D, Giugliano D, Sgambato S, Varricchio .M, and D'Onofrio F. Plasma vitamin C affects glucose homeostasis in healthy subjects and in non-insulin-dependent diabetics. Am J Physiol 266: E261-268, 1994.
105. Paolisso G, D'Amore A, Volpe C, Balbi V, Saccomanno F, Galzerano D, Giugliano D, Varricchio M, and D'Onofrio F. Evidence for a relationship between oxidative stress and insulin action in non-insulin-dependent (type II) diabetic patients. Metabolism 43: 1426-1429, 1994.
106. Paolisso G, Balbi V, Volpe C, Varricchio G, Gambardella A, Saccomanno F, Ammendola S, Varricchio M, and D'Onofrio F. Metabolic benefits deriving from chronic vitamin C supplementation in aged non-insulin dependent diabetics. J Am Coll Nutr 14: 387-392, 1995.
107. Paolisso G, Gambardella A, Tagliamonte MR. Saccomanno F, Salvatore T, Gualdiero P, D'Onofrio MV, and Howard BV. Does free fatty acid infusion impair insulin action also through an increase in oxidative stress? J Clin Endocrinol Metab 81: 4244-4248, 1996.
108. Patti, ME; Virkamaki A, Landaker EJ, Kahn CR, and Yki-Jarvinen H. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. Diabetes 48: 1562-1571, 1999.
109. Paz K, Hemi R, LeRoith D, Karasik A, Elhanany E, Kanety H, and Zick Y. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem 272: 29911-29918, 1997.
110. Pessler D, Rudich A, and Bashan N. Oxidative stress impairs nuclear proteins binding to the insulin responsive element in the GLUT4 promoter. Diabetologia 44: 2156-2164, 2001.
111. Pinkus R, Weiner LM, and Daniel V Role of oxidants and antioxidants in the induction of AP-1, NF-kappaB, and glutathione S-transferase gene expression. J Biol Chem 271: 13422-13429, 1996.
112. Pinzani P, Petruzzi E, Orlando C, Gallai R, Serio M, and Pazzagli M. Serum antioxidant capacity in healthy and diabetic subjects as determined by enhanced chemiluminescence. J Biolumin Chemilumin 13: 321-325, 1998.
113. Pirola L, Bonnafous S, Johnston AM, Chaussade C, Portis F, and Van Obberghen E. Phosphoinositide 3-kinase-mediated reduction of insulin receptor substrate-1/2 protein expression via different mechanisms contributes to the insulin-induced desensitization of its signaling pathways in L6 muscle cells. J Biol Chem 278: 15641-15651, 2003.
114. Potashnik R, Bloch-Damti A, Bashan N, and Rudich A. IRS1 degradation and increased serine phosphorylation cannot predict the degree of metabolic insulin resistance induced by oxidative stress. Diabetologia 46: 639-648. 2003.
115. Qi C and Pekala PH. Tumor necrosis factor-alpha-induced insulin resistance in adipocytes. Proc Soc Exp Biol Med 223: 128-135, 2000.
116. Rice KM, Turnbow MA, and Garner CW. Insulin stimulates the degradation of IRS-1 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 190: 961-967, 1993.
117. Robertson RP, Harmon J, Tran PO, and Poitout Y Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53(Suppl 1): S119-S124, 2004.
118. 5-methyldeoxycytosine on transcription from nuclear gene promoters in barley. Plant J 7: 221-233, 1995.
119. Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ, and Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 17: 189-212, 2001.
120. Ross SA, Chen X, Hope HR, Sun S, McMahon EG, Broschat K, and Gulve EA. Development and comparison of two 3T3-L1 adipocyte models of insulin resistance: increased glucose flux vs glucosamine treatment. Biochem Biophys Res Commun 273: 1033-1041, 2000.
121. Rudich A and Klip A. Push/pull mechanisms of GLUT4 traffic in muscle cells. Acta Physiol Scand 178: 297-308, 2003.
122. Rudich A, Kozlovsky N, Potashnik R, and Bashan N. Oxidant stress reduces insulin responsiveness in 3T3-L1 adipocytes. Am J Physiol 272: E935-E940, 1997.
123. Rudich A, Tirosh A, Potashnik R, Hemi R, Kanety H, and Bashan N. Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes 47: 1562-1569, 1998.
124. Rudich A, Tirosh A, Potashnik R, Khamaisi M. and Bashan N. Lipoic acid protects against oxidative stress induced impairment in insulin stimulation of protein kinase B and glucose transport in 3T3-L1 adipocytes. Diabetologia 42: 949-957, 1999.
125. Salonen JT, Nyyssonen K, Tuomainen TP, Maenpaa PH, Korpela H, Kaplan GA, Lynch J, Helmrich SP, and Salonen R. Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentrations: a four year follow up study in men. BMJ 311: 1124-1127, 1995.
126. Samiec PS, Drews-Botsch C, Flagg EW, Kurtz JC, Sternberg P Jr, Reed RL, and Jones DP. Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radic Biol Med 24: 699-704, 1998.
127. Santini SA, Marra G, Giardina B, Cotroneo P, Mordente A, Martorana GE, Manto A, and Ghirlanda G. Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes 46: 1853-1858, 1997.
128. Sargeant RJ and Paquet MR. Effect of insulin on the rates of synthesis and degradation of GLU-T1 and GLUT4 glucose transporters in 3T3-L1 adipocytes. Biochem J 290: 913-919, 1993.
129. 2+ signalling in diabetic patients is due to increased formation of Superoxide anions and reduced nitric oxide production. Diabetologia 42: 167-176, 1999.
130. Schleicher ED, Wagner E, and Nerlich AG. Increased accumulation of the glycoxidation product Ne(carboxymethyl) lysine in human tissues in diabetes and aging. J Clin Invest 99: 457-468, 1997.
131. Sen CK and Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 10: 709-720, 1996.
132. Shepherd PR, Withers DJ, and Siddle K. Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem J 333: 471-490, 1998.
133. Shi Y, Liu H, Vanderburg G, Samuel SJ, Ismail-Beigi F, and Jung CY. Modulation of GLUT1 intrinsic activity in clone 9 cells by inhibition of oxidative phosphorylation. J Biol Chem 210: 21772-21778, 1995.
134. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 106: 171-176, 2000.
135. Sinclair AJ, Girling AJ, Gray L, Le Guen C, Lunec J, and Barnett AH. Disturbed handling of ascorbic acid in diabetic patients with and without microangiopathy during high dose ascorbate supplementation. Diabetologia 34: 171-175, 1991.
136. Singh S, Melkani GC, Rani C, Gaur SP, Agrawal V, and Agrawal CG. Oxidative stress and metabolic control in non-insulin dependent diabetes mellitus. Indian J Biochem Biophys 34: 512-517, 1997.
137. Skrha J and Hilgertova J. Relationship of serum N-acetylbeta- glucosaminidase activity to oxidative stress in diabetes mellitus. Clin Chim Acta 282: 167-174, 1999.
138. Stenbit AE, Tsao TS, Li J, Burcelin R, Geenen DL, Factor SM, Houseknecht K, Katz EB, and Charron MJ. GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes. Nat Med 3: 1096-1101, 1997.
139. Streeper RS, Henriksen EJ, Jacob S, Hokama JY, Fogt DL, and Tritschler HJ. Differential effects of lipoic acid stereoisomers on glucose metabolism in insulin-resistant skeletal muscle. Am J Physiol 273: E185-E191, 1997.
140. Stringer MD, Gorog PG, Freeman A, and Kakkar VY Lipid peroxides and atherosclerosis. BMJ 298: 281-284, 1989.
141. Strodter D, Lehmann E, Lehmann U, Tritschler HJ, Bretzel RG, and Federlin K. The influence of thioctic acid on metabolism and function of the diabetic heart. Diabetes Res Clin Pract 29: 19-26, 1995.
142. Sundaram RK, Bhaskar A, Vijayalingam S, Viswanathan M, Mohan R, and Shanmugasundaram KR. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci (Lond) 90: 255-260, 1996.
143. Tanti JF, Gremeaux T, Grillo S, Calleja V, Klippel A, Williams LT, Van Obberghen E, and Le Marchand-Brustel Y. Overexpression of constitutively active form of phosphatidylinositol 3-kinase is sufficient to promote Glut 4 translocation in adipocytes. J Biol Chem 271: 25227-25232, 1996.
144. Thomas G, Skrinska V, Lucas FV, and Schumacher OR Platelet glutathione and thromboxane synthesis in diabetes. Diabetes 34: 951-954, 1985.
145. Thornalley PJ, McLellan AC, Lo TW, Benn J, and Sonksen PH. Negative association between erythrocyte reduced glutathione concentration and diabetic complications. Clin Sci (Lond) 91: 575-582, 1996.
146. Tirosh A, Potashnik R, Bashan N, and Rudich A. Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. A putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation. J Biol Chem 274: 10595-10602, 1999.
147. Tremblay F and Marette A. Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. J Biol Chem 276: 38052-38060, 2001.
148. Tremblay F, Lavigne C, Jacques H, and Marette A. Defective insulin-induced GLUT4 translocation in skeletal muscle of high fat-fed rats is associated with alterations in both Akt/protein kinase B and atypical protein kinase C (zeta/lambda) activities. Diabetes 50: 1901-1910, 2001.
149. Tsai EC, Hirsch IB, Brunzell JD, and Chait A. Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 43: 1010-1014, 1994.
150. Tsakiridis T, McDowell HE, Walker T, Downes CP, Hundal HS, Vranic M, and Klip A. Multiple roles of phosphatidylinositol 3-kinase in regulation of glucose transport, amino acid transport, and glucose transporters in L6 skeletal muscle cells. Endocrinology 136: 4315-4322, 1995.
151. Vandewoude MG, van Gaal LF, Vandewoude MF, and De Leeuw IH. Vitamin E status in normocholesterolemic and hypercholesterolemic diabetic patients. Acta Diabetol Lat 24: 133-139, 1987.
152. Vanhaesebroeck B and Alessi DR. The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 346: 561-576, 2000.
153. Varvarovska J, Racek J, Stozicky F, Soucek J, Trefil L, and Pomahacova R. Parameters of oxidative stress in children with type 1 diabetes mellitus and their relatives. J Diabetes Complications 17: 7-10, 2003.
154. Vessby J, Basu S, Mohsen R, Berne C, and Vessby B. Oxidative stress and antioxidant status in type 1 diabetes mellitus. J Intern Med 251: 69-76, 2002.
155. Wang T, Zhang X, and Li JJ. The role of NF-kappaB in the regulation of cell stress responses. Int Immunopharmaco 12: 1509-1520, 2002.
156. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, and Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808, 2003.
157. White MF. IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab 283: E413-E422, 2002.
158. Wientjes FB and Segal AW NADPH oxidase and the respiratory burst. Semin Cell Biol 6: 357-365, 1995.
159. Will JC, Ford ES, and Bowman BA. Serum vitamin C concentrations and diabetes: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 70: 49-52, 1999.
160. Willems D, Dorchy H, and Dufrasne D. Serum antioxidant status and oxidized LDL in well-controlled young type 1 diabetic patients with and without subclinical complications. Atherosclerosis 137 Suppl: S61-S64, 1998.
161. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, and Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112: 1821-1830, 2003.
162. Yang J, Clarke JF, Ester CJ, Young PW, Kasuga M, and Holman GD. Phosphatidylinositol 3-kinase acts at an in tracellular membrane site to enhance GLUT4 exocytosis in 3T3-L1 cells. Biochem J 313: 125-131, 1996.
163. Yaworsky K, Somwar R, Ramlal T, Tritschler HJ, and Klip A. Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by alpha-lipoic acid in 3T3-L1 adipocytes. Diabetologia 43: 294-303, 2000.
164. Yoshida K, Hirokawa J, Tagami S, Kawakami Y, Urata Y, and Kondo T. Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: regulation of glutathione synthesis and efflux. Diabetologia 38: 201-210, 1995.
165. Yue DK, McLennan S, McGill M, Fisher E, Heffernan S, Capogreco C, and Turtle JR. Abnormalities of ascorbic acid metabolism and diabetic control: differences between diabetic patients and diabetic rats. Diabetes Res Clin Pract 9: 239-244, 1990.